Metabolic syndrome and the menopause

Menopause International

Volumn 14, Issue 1, 2008, Pages 21-25

  Kaaja, Risto J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cardiovascular disease; Diabetes; Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE;

ABDOMINAL OBESITY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET THERAPY; DYSLIPIDEMIA; ESTROGEN THERAPY; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MENOPAUSE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; PHYSICAL ACTIVITY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREVALENCE; REVIEW; WEIGHT REDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; RISK REDUCTION;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INSULIN RESISTANCE; MENOPAUSE; METABOLIC SYNDROME X; PREVALENCE; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 47249135502     PISSN: 13621807     EISSN: 17404568     Source Type: Journal    
DOI: 10.1258/mi.2007.007032     Document Type: Review

References (65)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607 (Pubitemid 19004941)
2. Hu G, Qiao Q, Tuomilehto J. The metabolic syndrome and cardiovascular risk. Curr Diab Rev 2005;1:137-143
3. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998;20:157-172 (Pubitemid 29045104)
4. Laaksonen DE, Lakka HM, Niskanen LK, et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in prospective cohort study. Am J Epidemiol 2002;156:1070-1077 (Pubitemid 35396938)
5. Lorenzo C, Okoloise M,Williams K, et al. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 2003;26:3153-3159 (Pubitemid 37339513)
6. Wang JJ, Hu G, Miettinen ME, Tuomilehto J. The metabolic syndrome and incident diabetes: assessment of four suggested definitions of the metabolic syndrome in a Chinese population with high post-prandial glucose. Horm Metab Res 2004;36:708-715 (Pubitemid 39486972)
7. Wang JJ, Li HB, Kinnunen L, et al. How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population? Atherosclerosis 2007;192:161-168
8. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716 (Pubitemid 35403784)
9. Hu G, Qiao Q, Tuomilehto J, et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004;164:1066-1076 (Pubitemid 38668985)
10. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-1778 (Pubitemid 40923091)
11. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-414 (Pubitemid 46135879)
12. Qiao Q, Gao W, Zhang L, et al. Metabolic syndrome and cardiovascular disease. Ann Clin Biochem 2007;44:232-263
13. WHO Consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organisation, 1999
14. National Institute of Health. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-2497
15. Spencer CP, Godsland IF, Stevenson JC. Is there a menopausal metabolic syndrome? Gynecol Endocrinol 1997;11:341-355
16. Sipilä K, Koivistoinen T, Moilanen L, et al. Metabolic syndrome and arterial stiffness. The health 2000 survey. Metabolism 2007;56:320-326
17. Qiao Q. The DECODE study group. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006;49:2837-2846
18. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 2002;287:356-359 (Pubitemid 34251969)
19. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553
20. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16:442-443
21. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-2497
22. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9:237-252
23. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology task force consensus group. The metabolic syndrome: a new worldwide definition. Lancet 2005;366:1059-1062
24. Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735-2752
25. Kahn R, Buse J, Ferranini E, Stern M, American Diabetes Association, European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304
26. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004;27:2444-2449 (Pubitemid 39281399)
27. Lorenzo C, Williams K, Gonzalez-Villalpando C, Haffner SM. The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity. Diabetes Care 2005;28:2480-2485
28. Lorenzo C, Williams K, Hunt KJ, Haffner SM. Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. Diabetes Care 2006;29:625-630 (Pubitemid 44115364)
29. Park HS, Kim SM, Lee JS, et al. Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998-2001. Diabetes Obes Metab 2007;9:50-58
30. Pajak A, Kuulasmaa K, Tuomilehto J, Ruokokoski. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. The WHO MONICA Project. World Health Stat Quarterly 1988;41:115-140
31. Hu G, Qiao Q, Silventoinen K, et al. Occupational, commuting, and leisure-time physical activity in relation to risk for type 2 diabetes in middle-aged Finnish men and women. Diabetologia 2003;46:322-329 (Pubitemid 36547586)
32. Hu G, Tuomilehto J, Borodulin K, Jousilahti P. The joint associations of occupational, commuting, and leisure-time physical activity, and the Framingham risk score on the 10-year risk of coronary heart disease. Eur Heart J 2007;28:492-498 (Pubitemid 47343562)
33. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary artery disease. Arch Intern Med 1999;159:1104-1109 (Pubitemid 29230863)
34. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119:812-819 (Pubitemid 44415613)
35. Fox CS, Massaro JM, Hoffman U, et al. Abdominal visceral adipose tissue compartments, association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48 (Pubitemid 47016245)
36. Shamsuzzaman A, Winnicki M, Wolk R, et al. Independent asoociation between plasma leptin and C-reactive protein in healthy humans. Circulation 2004;109:2181-2185 (Pubitemid 38625394)
37. Nakanishi N, Shiraishi T, Wada M. C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: the Minoh study. Circ J 2005;69:386-391 (Pubitemid 40502327)
38. Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens 1989;3:427-433
39. Crawford SL, Casey VA, Avis NE, McKinlay SM. A longitudinal study of weight and the menopause transition: results from the Massachusetts Women's Health Study. Menopause 2000;7:96-104 (Pubitemid 30151396)
40. Toth MJ, Tchernof A, Sites CK, Poehlman ET. Effects of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disor 2000;24:226-231 (Pubitemid 30107573)
41. Kongnyyuy E, Norman RJ, Flight IHK, Rees MCP. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database Syst Rev 2007;(2):CD001018
42. Toth MJ, Sites CK, Eltabbakh GH, Poehlman ET. Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. Diabetes 2000;23:801-806 (Pubitemid 30414197)
43. Lasco A, Alvaro S, Frisina N, Di Benedetto A, Denzzo G, Cucinotta D. Long-term transdermal estrogen therapy improves lipid profile but not insulin resistance in healthy postmenopausal women. Diabetes Care 2000;23:422-424 (Pubitemid 30131759)
44. Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC. The effect of the menopause on insulin sensitivity, secretion and elimination in non-obese healthy women. Eur J Clin Invest 1993;23:466-473 (Pubitemid 23243937)
45. Guthrie JR, Ball M, Dudley EC, et al. Impaired fasting glycaemia in middle-aged women: a prospective study. Int J Obes Relat Metab Disord 2001;25:646-651 (Pubitemid 32417633)
46. DeNino WF, Tchernof A, Dionne IJ, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001;24:925-932 (Pubitemid 33636071)
47. Salpeter SR, Walsh JME, Ormiston TM, et al. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 2006;8:538-554 (Pubitemid 44184248)
48. Bonds DE, Lasser N, Qi L, et al. The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia 2006;49:459-468 (Pubitemid 43277868)
49. Crook D, Godsland IF, Hull J, Stevenson JC. Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up. Br J Obstet Gynaecol 1997;104:298-304 (Pubitemid 27112660)
50. Spencer CP, Godsland IF, Cooper AJ, Ross D, Whitehead MI, Stevenson JC. Effects of oral and transdermal 17 beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. Metabolism 2000;49:742-747 (Pubitemid 30354581)
51. Ehrmann DA. Medical progress: polycystic ovary syndrome. New Engl J Med 2005;352:1223-1236 (Pubitemid 41007836)
52. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 2004;19:41-47
53. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN; PCOS/Troglitazone Study Group. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:48-53 (Pubitemid 44536889)
54. Krentz AJ, von Muhlen D, Barrett-Connor E. Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease. Menopause 2007;14:284-292 (Pubitemid 46673480)
55. Bentley-Lewis R, Koruda K, Seely EW. The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab 2007;3:696-704
56. Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996;81:2908-2911 (Pubitemid 26323884)
57. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862-1868
58. Di Cianni G, Lencioni C, Volpe L, et al. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 2007;23:135-140 (Pubitemid 46306434)
59. Kaaja R, Pöyhönen-Alho MK. Insulin resistance and sympathetic overactivity. J Hypertens 2006;24:131-141
60. Narkiewicz K, Phillips BG, Kato M, et al. Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension. 2005;45:522-525 (Pubitemid 40411253)
61. Kaaja R, Kujala S, Manhem K, et al. Effects of sympatholytic therapy on insulin indices in hypertensive postmenopausal women. In J Clin Pharm Ther 2007;45:394-401 (Pubitemid 47045482)
62. Pan X, Li G, Hu Y, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-544
63. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350 (Pubitemid 32378388)
64. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403 (Pubitemid 34437694)
65. Messerli FH, Grossman E, Leonetti G. Antihypertensive therapy and new onset diabetes. J Hypertens 2004;22:1845-1847 (Pubitemid 39336662)